Sandoz International GmbH
Sandoz International GmbH, a leading global player in the pharmaceutical industry, is headquartered in Holzkirchen, Germany. Founded in 1886, Sandoz has established itself as a pioneer in generic pharmaceuticals and biosimilars, serving patients across Europe, North America, and beyond. The company is renowned for its commitment to high-quality, affordable medicines, offering a diverse portfolio that includes antibiotics, oncology products, and complex generics. Sandoz's innovative approach to drug development and manufacturing sets it apart in a competitive market, enabling it to maintain a strong position as a trusted provider of essential healthcare solutions. With a focus on sustainability and access to medicines, Sandoz continues to achieve significant milestones, reinforcing its reputation as a leader in the global healthcare landscape.
DitchCarbon Score
How does Sandoz International GmbH's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Sandoz International GmbH's score of 22 is lower than 85% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Sandoz International GmbH's reported carbon emissions
Sandoz International GmbH, headquartered in Germany, currently does not have publicly available carbon emissions data for the most recent year. As a result, specific figures regarding their Scope 1, 2, or 3 emissions are not provided. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. In the absence of specific emissions data, it is important to note that Sandoz, as a key player in the pharmaceutical industry, is likely to be engaged in various sustainability efforts aligned with industry standards. Companies in this sector are increasingly focusing on reducing their carbon footprint and enhancing their climate commitments to meet global climate goals. While Sandoz has not disclosed specific targets or achievements, the pharmaceutical industry as a whole is under pressure to adopt more sustainable practices, which may include setting science-based targets and committing to net-zero emissions in the future.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Sandoz International GmbH is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
